4th Quarter - Report — TERUMO BCT, INC. for TERUMO BCT, INC. (2023)

Firm

TERUMO BCT, INC.

Client

TERUMO BCT, INC.

Income

—

Expenses

$200,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-Access to Therapeutic Apheresis, generally. -Sickle Cell Disease issues, generally; S.1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023. -Blood collection issues, generally. -Medical device sterilization.

Lobbyist	Covered position, as disclosed
ANDREA HECHAVARRIA	Legislative Assistant to Senator Joni Ernst; Legislative Assistant, Legislative Aide & Legislative Correspondent to Senator Mike Johanns; Staff Assistant to Senator Judd Gregg; Staff Assistant to Senator John E. Sununu

Contacted: Environmental Protection Agency (EPA); SENATE; Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES

Bills named: S. 1852 (118th)

Medicare/Medicaid MMM

-Access to Therapeutic Apheresis, generally. -Issues related to CY 2024 Physician Fee Schedule. -Issues related to CY 2024 OPPS Proposed Rule. -Sickle Cell Disease issues, generally.

Lobbyist	Covered position, as disclosed
ANDREA HECHAVARRIA	Legislative Assistant to Senator Joni Ernst; Legislative Assistant, Legislative Aide & Legislative Correspondent to Senator Mike Johanns; Staff Assistant to Senator Judd Gregg; Staff Assistant to Senator John E. Sununu

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.